Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer

Daniel E. Spratt, Jingbin Zhang, Maria Santiago-Jiḿenez, Robert T. Dess, John W. Davis, Robert B. Den, Adam P. Dicker, Christopher J. Kane, Alan Pollack, Radka Stoyanova, Firas Abdollah, Ashley E. Ross, Adam Cole, Edward Uchio, Josh M. Randall, Hao Nguyen, Shuang G. Zhao, Rohit Mehra, Andrew G. Glass, Lucia L.C. LamJijumon Chelliserry, Marguerite Du Plessis, Voleak Choeurng, Maria Aranes, Tyler Kolisnik, Jennifer Margrave, Jason Alter, Jennifer Jordan, Christine Buerki, Kasra Yousefi, Zaid Haddad, Elai Davicioni, Edouard J. Trabulsi, Stacy Loeb, Ashutosh Tewari, Peter R. Carroll, Sheila Weinmann, Edward M. Schaeffer, Eric A. Klein, R. Jeffrey Karnes, Felix Y. Feng, Paul L. Nguyen

Research output: Contribution to journal › Article › peer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences